Volume 9, Number 9—September 2003
Ehrlichia chaffeensis Infections among HIV-infected Patients in Human Monocytic Ehrlichiosis–Endemic Area
|Characteristic||N (% or range)|
|Age (mean, y)
|Baseline CD4 count (median, cells/mm3)
|Baseline viral load (median, copies/dL)
|Average number of clinic visitsd
|Treated with antibiotic therapyd,e
|Treated with doxycyclined
aHAART, highly active antiretroviral therapy; OI, opportunistic infection; PCP, Pneumocystis carinii pneumonia; MAC, Mycobacterium avium complex.
bPCP prophylaxis: use of trimethoprim-sulfamethoxazole, dapsone, or aerosolized pentamidine therapy.
cMAC prophylaxis: use of azithromycin or clarithromycin therapy.
dDuring the study period.
eAntibiotics used to treat the ongoing clinical symptoms; persons taking antibiotic therapy specifically for OI prophylaxis alone were not included.
- Page created: January 03, 2011
- Page last updated: January 03, 2011
- Page last reviewed: January 03, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)